Clinical Trial Update: Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating whether vaginal delivery of combined hormonal contraception affects the risk of metabolic syndrome in overweight o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Andrea Roe, MD, MPH | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED